©OX1 Incubator 2019

  • Facebook
  • LinkedIn Social Icon

Meet the Cohort 2018/19

Operon (formerly Coli)
Multiplatform lab work management application

Operon aims to improve the efficiency of science with software. Science is held back by the way scientists manage their lab work. Operon is a multiplatform ELN application to easily set up, execute and record experiments from the desktop to the bench-top. Unlike competitors, it is both easy-to-use and ready for bench-top integration.

Reza Rohani

(Team Lead)

PhD Bioengineering

  • Grey LinkedIn Icon

Serbald Verkuijl

(Product)

PhD Interdisciplinary Biosciences

Stefan Leape (Business)

MSc Biochemistry undergraduate

  • Grey LinkedIn Icon
AllGood
Elderly care app that helps you checks on loved ones

AllGood was founded on the belief that families shouldn't have to worry about their elderly loved ones living alone. All current solutions entail functional, emotional, and economic compromises. As 40% of seniors have a smartphone, AllGood decided to solve this problem with a simple mobile application. It provides an alternative to obsolete panic buttons (of which half are never worn).

Maggie Chen

MPhil Languages undergraduate

  • Grey LinkedIn Icon

Carlo Quadrio Curzio

BA Human Sciences

  • Grey LinkedIn Icon

Benjamin Griffiths

DPhil Quantum Physics

  • Grey LinkedIn Icon

Daniel Ma

BSc Computer Science

Neurolytics (formerly Rebndl)
Intelligent digital news subscription

Rebndl is on the verge of transforming the news publishing industry. Currently, 67% of people read the news online for free, and are increasingly looking to access a highly curated selection of news stories on their smartphones. Through its digital news subscription platform, Rebndl integrates the emerging trends in news consumption behaviour with the changing business demands of newspapers to shape the future of news publishing.

After having been equipped with the skills needed to found a start-up in the OX1 Incubator, the original Rebndl team moved on to a new idea: Neurolytic Healthcare Ltd. They have already received funding from two sources and have a headcount of 10 dedicated team members including a prominent advisory board.

Neurolytic Healthcare Ltd. delivers AI-driven real-time event prediction and pharmacogenomic testing for neurological disorders to improve patient quality of life and help clinicians optimise prescription decisions. It draws on recent advances and successes in personalised medicine and pharmacogenomics, supported by NHS England's aim to embed personalised healthcare across the NHS. Given the current suboptimal management of neurological disorders and lack of specialised healthcare staff in the UK, there remains a significant unmet need for digital healthcare providers who can deliver effective neurological event prediction prediction tools and a systematic optimisation of pharmacological treatment. By covering and personalising the complete treatment pathway, Neurolytic Healthcare ensures improved quality of life and optimised clinical decision-making, whilst reducing the significant costs to the economy and healthcare system. 

Roman Rothärmel

DPhil Neuroscience

  • Grey LinkedIn Icon

Tom Kent

DPhil Medical Science

  • Grey LinkedIn Icon
Artale
Art marketplace platform developing limited editions of art derivatives

The Chinese Authorised Art Derivatives market has an estimated size of 10 billion USD. Yet, it still has untapped opportunities. Artale addresses four primary issues faced by artists (lack of knowledge of how to monetise their art beyond galleries; lack of motivation to seek potential buyers; no market for the transactions of mid-tier artists’ works; and limited digital means to display and sell their art) and two issues faced by customers (middle income families do not have sufficient income to purchase high end artworks; and many potential customers are unaware of the range of offerings of the art market).

Lucy Li

BA Economics and Management undergraduate

  • Grey LinkedIn Icon

Lena Ma

MBA

Helen Chan

British and European studies

Intrepidus
App using CBT to overcome the fear of needles

The current solutions to a fear of needs (talking therapies, distraction and relaxation) are either ineffective or expensive and inconvenient. Intrepidus provides convenient, low-cost, therapy-quality care to help people overcome their fear of needles. It does so via an app powered by AI and CBT which identifies and challenges patients’ fears and unhelpful thoughts and behaviours.

Zaki Krag Nielsen

DPhil Medical Sciences

  • Grey LinkedIn Icon

Vlad Moldoveanu

MSc Mathematics and Computer Science

  • Grey LinkedIn Icon
Ceres
Fresh pasta making robot

Ceres tackles the ‘hungry person’s trilemma’: when choosing between convenient, affordable and healthy food, you can generally have at most two of the three. This trilemma is most noteworthy during the lunchtime rush, which presents a lucrative opportunity: the lunchtime market in the UK is £5 billion per annum and growing.

Ceres is creating a high-end pasta making robot that can deliver a fresh pasta meal from order to service in less than 3 minutes.

Walter Huang

MSc Financial Economics

Daniel Wells

DPhil Genomics

  • Grey LinkedIn Icon

Neil Wang

MSc Engineering

  • Grey LinkedIn Icon
GP Assist
Medical services at home

Many routine medical services that currently need a visit to the hospital could instead be performed at home, arranged through a local GP, saving time and hassle for everyone. Unfortunately, GPs are severely overworked. This means that they prefer sending patients to the hospital to home-visits. To solve this problem, GP Assist is building a cost-effective way to provide medical services at home, which can be provided by a GP via a simple prescription. GP Assist provides a postal diagnostic kit paired with a smartphone app, powered by oximetry and AI.

Niclas Palmius

DPhil Biomedical Engineering

Aditya Agarwal

MSc Computer Science

  • Grey LinkedIn Icon

Vira Ameli

DPhil Public Health

  • Grey LinkedIn Icon

Tommy Gorgy

MBA

  • Grey LinkedIn Icon